
The Advantage Efficacy of Intranasal Live-Attenuated Vaccine Against SARS-CoV-2
Author(s) -
Ratthaphum Sae-ngow
Publication year - 2022
Publication title -
international journal of science and healthcare research
Language(s) - English
Resource type - Journals
ISSN - 2455-7587
DOI - 10.52403/ijshr.20220715
Subject(s) - medicine , pandemic , clinical trial , attenuated vaccine , vaccine trial , vaccination , intensive care medicine , vaccine efficacy , covid-19 , clinical research , booster dose , immunology , disease , infectious disease (medical specialty) , immunization , immune system , biochemistry , chemistry , virulence , gene